Who
Carrie Smith Cox
Director
Company insider
Files Form 4 as: Director, Solventum; Director, Texas Instruments; Executive Chair, Organon & Co; Director, Cartesian Therapeutics; Director, Cardinal Health; Director, Celgene Corp /de/; Director, Array Biopharma; Director, electroCore.
In numbers
- Trades disclosed
- 284
- Buys
- 13
- Sells
- 11
- Bought
- $1.2M
- Sold
- $51.0M
- Companies
- 9
- Companies where not an officer
- 7
- First trade
- 19 Jan 2006
- Last trade
- 15 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 May 2026filed 18 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,848 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,848 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas InstrumentsSemiconductors | SEC FORM 4 Code M | $474K4,306 at $110.15 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas InstrumentsSemiconductors | SEC FORM 4 Code M | $473K4,532 at $104.41 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas InstrumentsSemiconductors | SEC FORM 4 Sold | $2.6M8,393 at $306.37 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas Instrumentsoption or derivative · Semiconductors | SEC FORM 4 Code M | —4,306 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas Instrumentsoption or derivative · Semiconductors | SEC FORM 4 Code M | —4,532 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas InstrumentsSemiconductors | SEC FORM 4 Sold | $137K445 at $307.04 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas Instrumentsoption or derivative · Semiconductors | SEC FORM 4 Code M | —4,306 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas Instrumentsoption or derivative · Semiconductors | SEC FORM 4 Code M | —4,532 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas InstrumentsSemiconductors | SEC FORM 4 Code M | $474K4,306 at $110.15 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas InstrumentsSemiconductors | SEC FORM 4 Code M | $473K4,532 at $104.41 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas InstrumentsSemiconductors | SEC FORM 4 Sold | $2.6M8,393 at $306.37 | filing |
| 13 May 2026filed 14 May 2026 | TXN Texas InstrumentsSemiconductors | SEC FORM 4 Sold | $137K445 at $307.04 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —4,916 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,916 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,916 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —4,916 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —6,336 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,336 at $0.00 | filing |
News
Texas Instruments (NASDAQ: TXN) revenue jumps and sets Q4 outlookTXN · themarketsdaily.com · 22 Oct 2026Texas Instruments (NASDAQ:TXN) Stock Gets Price Target Cut from MizuhoTXN · dailypolitical.com · 22 Oct 2026Critical Contrast: Organon & Co. (NYSE:OGN) & Xeris Biopharma (NASDAQ:XERS)OGN · tickerreport.com · 21 Oct 2026Head-To-Head Survey: Organon & Co. (NYSE:OGN) versus Xeris Biopharma (NASDAQ:XERS)OGN · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Carrie Smith Cox; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.